Aging and the nigro-striatal pathway

Journal of Neural Transmission, Supplement

Volumn , Issue 51, 1997, Pages 9-25

  Cruz Sanchez F F ^a,b   Cardozo, A ^a   Castejon C ^a   Tolosa, E ^a   Rossi, M L ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR;

AGED; AGING; BRAIN MATURATION; CLINICAL PROTOCOL; COGNITIVE DEFECT; CONFERENCE PAPER; CYTOSKELETON; HUMAN; LIFESTYLE; MENTAL FUNCTION; MOTOR DYSFUNCTION; NIGRONEOSTRIATAL SYSTEM; PRIORITY JOURNAL; TISSUE PRESERVATION; ANIMAL; GROWTH, DEVELOPMENT AND AGING; NEOSTRIATUM; NERVE DEGENERATION; NERVE TRACT; PATHOLOGY; PHYSIOLOGY; REVIEW; SUBSTANTIA NIGRA;

AGED; AGING; ANIMALS; HUMANS; NEOSTRIATUM; NERVE DEGENERATION; NEURAL PATHWAYS; SUBSTANTIA NIGRA;

EID: 0031283212     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6846-2_2     Document Type: Conference Paper

References (58)

1. Arriagada PV, Marzloff K, Hyman BT (1992) Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease. Neurology 42: 1681-1688
2. Beck KD, Valverde J, Alexi T, Poulsen K, Moffat B, Vandlen R, Rosenthal A, Hefti F (1995) Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature 373: 339-341
3. Boatell MLl, Mahy N, Cardozo A, Ambrosio S, Tolosa E, Cruz-Sánchez FF (1992) Neuronal changes in the nigrostriatal pathway of 1-Methl-4-Phenylpyridine- treated mice. Meth Find Exp Clin Pharmacol 14(10): 781-787
4. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82: 239-259
5. Burgoyne RD, Cambray-Deakin MA (1988) The cellular neurobiology of neuronal development: the cerebellar granule cell. Brain Res Rev 13: 77-101
6. Calne DB, Peppard RF (1987) Aging of the nigrostriatal pathway in humans. Can J Neurol Sci 14: 424-427
7. Calne DB, Eisen A, McGeer E, Spencer P (1986) Alzheimer's disease, Parkinson's disease and motor neurone disease: abiotrophic interaction between ageing and environment? Lancet (Nov 8): 1067-1070
8. Cheng B, Mattson MP (1994) NT-3 and BDNF protect CNS neurons against metabolic/ excitotoxic insults. Brain Res 640: 56-67
9. Crutcher KA (1990) Age-related decrease in sympathetic sprouting is primarily due to decreased target receptivity: implications for understanding brain aging. Neurobiol Aging 11: 175-183
10. Cruz-Sánchez FF (1994) Antigenic determinant properties of neurofibrillary tangles. Relevance to progressive supranuclear palsy. J Neural Transm [Suppl] 42: 165-178
11. Cruz-Sánchez FF, Cardozo A, Ambrosio S, Tolosa E, Mahy N (1993) Plasticity of the nigrostriatal system in MPTP-treated mice. Mol Chem Neuropathol 19: 163-176
12. Cruz-Sánchez FF, Cardozo A, Tolosa E (1995) Neuronal changes in the substantia nigra with aging: a Golgi study. J Neuropathol Exp Neurol 54: 74-81
13. Daniel SE (1995) Parkinson's disease. In: Cruz-Sánchez FF, Ravid R, Cuzner ML (eds) Neuropathological diagnostic criteria for brain banking. IOS Press, Amsterdam
14. Fearnley JM, Lees AJ (1991) Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 114: 2283-2301
15. Finch CE, Morgan DG (1990) RNA and protein metabolism in the aging brain. Ann Rev Neurosci 13: 75-87
16. Gibb WRG, Lees AJ (1991) Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease. J Neurol Neurosurg Psychiatry 54: 388-396
17. Gsell W, Lange KW, Pfeuffer R, Heckers S, Heisen H, Senitz D, Jellinger K, Ransmayr G, Wichart I, Vock R, Beckmann H, Riederer P (1993) How to run a brain bank. A report from the Austro-German brain bank. J Neural Transm [Suppl] 39: 31-70
18. Haas AL, Bright PM (1985) The immunochemical detection and quantification of intra-cellular ubiquitin-protein conjugates. J Biol Biochem 260: 12464-12473
19. Hodge CF (1894) Changes in the ganglion cells from birth to senile death. Observations on man and honey-bee. J Physiol 17: 129-134
20. Jelsma TN, Aguayo AJ (1994) Trophic factors. Curr Opin Neurobiol 4: 717-725
21. Kaminska B, Kaczmarek L (1993) Robust induction of AP-1 transcription factor DNA binding activity in the hippocampus of aged rats. Neurosci Lett 153: 189-191
22. Landfield PW, Rose G, Sandles L, Wohlstadter TC, Lynch G (1994) Patterns of astroglial hypertrophy and neuronal degeneration in the hippocampus of aged, memory-deficient rats. J Gerontol 32: 3-12
23. Leigh PN, Probst A, Dale GE, Power DP, Brion J-P, Dodson A, Anderton BH (1989) New aspects of the pathology of neurodegenerative disorders as revealed by ubiquitin antibodies. Acta Neuropathol (Berl) 79: 61-72
24. Lindsay RM (1995) Neuron saving schemes. Nature 373: 289-290
25. Lindsay RM, Wiegand SJ, Altar A, DiStefano P (1994) Neurotrophic factors: from molecule to man. TINS 17: 182-190
26. Linnemann D, Skarsfelt T (1994) Regional changes in expression of NCAM, GFAP, S100 in aging rat brain. Neurobiol Aging 15: 651-655
27. Linnemann D, Gaardsvoll H, Olsen M, Bock E (1993) Expression of NCAM mRNA and polypeptides in aging rat brain. Int J Dev Neurosci 11: 71-81
28. Lopez Torres M, Perz Campo R, Fernandez A, Barba C, Barja de Quiroga G (1993) Brain glutathione reductase induction increases early survival and decreases lipofuscin accumulation in aging frogs. J Neurosci Res 34: 233-242
29. Lowe J, Blanchard A, Morrel K, Lennox G, Reynolds L, Billet M, Landon M, Mayer RJ (1988) Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson's disease, Pick's disease and Alzheimer's disease, as well as Rosenthal fibres in cerebellar astrocytomas, cytoplasmic bodies in muscle and Mallory bodies in alcoholic liver disease. J Pathol 155: 9-15
30. Machado-Salas J, Scheibel ME, Scheibel AB (1977) Neuronal changes in the aging mouse: spinal cord and lower brain stem. Exp Neurol 54: 504-512
31. Magnoni MS, Govoni S, Battaini F, Trabucchi M (1991) The aging brain: protein phosphorylation as a target of changes in neuronal function. Life Sci 48: 373-385
32. Mann DMA, Yates PO (1974) Lipoprotein pigments - their relationship to ageing in the human nervous system. II. The melanin content of pigmented nerve cells. Brain 97: 489-498
33. Mann DMA, Yates PO, Marcyniuk B (1984) Monoaminergic neurotransmitter systems in presenile Alzheimer's disease and in senile dementia of Alzheimer type. Clin Neuropathol 3(5): 199-205
34. Mannetto V, Perry G, Tabaton M, Mulvihill P, Fried VA, Smith HT, Gambetti P, Autulio Gambetti L (1988) Ubiquitin is associated with abnormal cytoplasmic filaments characteristic of neurodegenerative diseases. Proc Natl Acad Sci USA 85: 4501-4505
35. McGeer PL, McGeer EG, Suzuki JS (1977) Aging and the extrapyramidal function. Arch Neurol 34: 33-35
36. Migheli A, Attanasio A, Pezzulo T, Gullotta F, Giordana MT, Schiffer D (1992) Age related ubiquitin deposits in dystrophic neuntes: an immunoelectron microscopic study. Neuropathol Appl Neurobiol 18: 3-11
37. Moral A, Cardozo A, Rossi M, Tolosa E, Cruz-Sánchez FF (1994) Spinal motor neurons in aging: a morphological and immunohistochemical study (Abstract). Brain Neuropathol 4: 577
38. Nixon RA (1993) The regulation of neurofilament protein dynamics by phosphorylation: clue to neurofibrillary pathobiology. Brain Pathol 3: 29-38
39. Patt S, Gertz HJ, Lieselote G, Cervós-Navarro J (1991) Pathological changes in dendrites of substantia nigra neurons in Parkinson's disease: a Golgi study. Histol Histopathol 6: 373-380
40. Ramón-Moliner E (1970) The Golgi-Cox technique. In: Nauta WJH, Ebbesson SOE (eds) Contemporary research methods in neuroanatomy. Springer, New York, pp 32-55
41. Ravid R, Swaab DF, van Zwieten EJ, Salehi A (1995) Controls are what makes a brain bank go round. In: Cruz-Sánchez FF, Ravid R, Cuzner ML (eds) Neuropathological diagnostic criteria for brain banks. IOS Press, Amsterdam, pp 4-13
42. Rechsteiner M (1991) Natural substrate of the ubiquitin proteolytic pathway. Cell 66: 615-618
43. Roth GS, Joseph JA, Preston Mason R (1995) Membrane alterations as causes of impaired signal transduction in Alzheimer's disease and aging. TINS 18: 203-206
44. Rylett RJ, Williams LR (1994) Role of neurotrophins in cholinergic-neurone function in the adult and aged CNS. TINS 17: 486-490
45. Selkoe DJ (1992) Aging brain, aging mind. Sci Am 267: 134-142
46. Smith MA, Sayre LM, Monnier VM, Perry G (1995) Radical ageing in Alzheimer's disease. TINS 18: 172-176
47. Scheibel ME, Scheibel AB (1970) The rapid Golgi method. Indian summer or renaissance? In: Nauta WJH, Ebbesson SOE (eds) Contemporary research methods in neuroanatomy. Springer, New York, pp 1-11
48. Scheibel ME, Lindsay RD, Tomiyasu U, Scheibel AB (1976) Progressive dendritic changes in the aging human limbic system. Exp Neurol 47: 392-403
49. Scheibel ME, Lindsay RD, Tomiyasu U, Scheibel AB (1977) The aging human Betz cell. Exp Neurol 56: 598-609
50. Teräväinen H, Calne DB (1983) Motor system in normal aging and Parkinson's disease. In: Katzman R, Terry R (eds) The neurology of aging. Davis, Philadelphia, pp 85-109
51. Thiessen B, Rajput AH, Laverty W, Desai H (1990) Age, environments and the number of substantia nigra neurons. In: Streifier MB, Korczyn AD, Melamed E, Youdim MBH (eds) Parkinson's disease: anatomy, pathology, and therapy. Raven Press, New York, pp 201-206 (Adv Neurol 53)
52. Tomac A, Lindqvist E, Lin LF H, Ögren SO, Young D, Hoffer BJ, Olson L (1995) Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 373: 335-339
53. Tomlinson BE, Irving D (1977) The number of motor neurons in the human Iumbosacral cord throughout life. J Neurol Sci 34: 213-219
54. Valverde F (1970) The Golgi method. A tool for comparative structural analyses. In: Nauta WJH, Ebbesson SOE (eds) Contemporary research methods in neuroanatomy. Springer, New York, pp 12-31
55. Vickers JC, Riederer BM, Marugg RA, Buée-Scerrer V, Buée L, Delacourte A, Morrison JH (1994) Alterations in neurofilament protein immunoreactivity in human hippocampal neurons related to normal aging and Alzheimer's disease. Neurosci 62(1): 1-13
56. Wiedenmann B, Franke W (1985) Identification and location of synapthophysin, an integral membrane glycoprotein of Mr 38,000 characteristic of presynaptic vesicles. Cell 41: 1017-1028
57. Williams EJ, Furness J, Walsh FS, Doherty P (1994) Activation of FGF receptor underlies neurite outgrowth stimulated by L1, N-CAM and N-cadherin. Neuron 13: 583-594
58. Yasuhara O, Kawamata T, Yoshinari A, McGeer EG, McGeer PL (1994) Two types of dystrophic neuntes in senile plaques of Alzheimer's disease and elderly non-demented cases. Neurosci Lett 171: 73-76